Hennion & Walsh Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.78M Sell
5,549
-1,375
-20% -$660K 0.08% 301
2026
Q1
$3.4M Buy
6,924
+136
+2% +$73.8K 0.11% 231
2025
Q4
$3.93M Buy
6,788
+1,602
+31% +$906K 0.14% 190
2025
Q3
$2.52M Sell
5,186
-29
-0.6% -$13.5K 0.09% 287
2025
Q2
$2.11M Sell
5,215
-1,139
-18% -$476K 0.09% 305
2025
Q1
$3.16M Buy
6,354
+1,658
+35% +$898K 0.14% 185
2024
Q4
$2.44M Buy
4,696
+2,094
+80% +$1.15M 0.11% 238
2024
Q3
$1.6M Sell
2,602
-1,746
-40% -$1.03M 0.07% 339
2024
Q2
$2.4M Sell
4,348
-973
-18% -$557K 0.12% 219
2024
Q1
$3.09M Sell
5,321
-1,863
-26% -$1.05M 0.17% 164
2023
Q4
$3.81M Sell
7,184
-294
-4% -$142K 0.22% 116
2023
Q3
$3.79M Sell
7,478
-3,165
-30% -$1.69M 0.24% 100
2023
Q2
$5.55M Sell
10,643
-1,479
-12% -$798K 0.33% 66
2023
Q1
$6.99M Sell
12,122
-2,062
-15% -$1.16M 0.43% 49
2022
Q4
$7.81M Sell
14,184
-492
-3% -$261K 0.48% 42
2022
Q3
$7.44M Sell
14,676
-4,149
-22% -$2.32M 0.49% 46
2022
Q2
$10.2M Sell
18,825
-1,428
-7% -$786K 0.63% 30
2022
Q1
$12M Sell
20,253
-697
-3% -$400K 0.64% 31
2021
Q4
$14M Buy
20,950
+1,732
+9% +$1.08M 0.69% 25
2021
Q3
$11M Sell
19,218
-593
-3% -$325K 0.58% 37
2021
Q2
$9.99M Buy
19,811
+379
+2% +$179K 0.53% 34
2021
Q1
$8.87M Buy
+19,432
New +$9.27M 0.53% 31

Other funds holding TMO

Hennion & Walsh Asset Management's TMO Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 20% in Q2 2026, selling an estimated $660K and leaving 5,549 shares worth $2.78M. The position accounts for 0.08% of the portfolio, ranked #301.

Hennion & Walsh Asset Management first reported a position in TMO in Q1 2021 and has held it in 22 quarters since. The position peaked at $14M in Q4 2021. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Hennion & Walsh Asset Management held 5,549 shares of Thermo Fisher Scientific worth $2.78M as of Q2 2026.
  • Hennion & Walsh Asset Management sold 1,375 Thermo Fisher Scientific shares in Q2 2026, an estimated $660K.
  • Thermo Fisher Scientific made up 0.08% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #301 holding.
  • Hennion & Walsh Asset Management first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 22 quarters since.
  • Hennion & Walsh Asset Management's Thermo Fisher Scientific position peaked at $14M in Q4 2021.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.